Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.38497.506481.8F (Published 16 June 2005) Cite this as: BMJ 2005;330:1423All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Since publication of the report of our clinical study using 4%
dimeticone lotion to treat head louse infestation,[1] I have received
numerous enquiries about just how dimeticone fits in with current
approaches to head louse treatment. More recently I have been made aware
of a related debate that has circulated amongst members of the Public
Health Environmental Group (PHMEG) and has also been raised by several of
the local Minor Ailment and Pharmacist prescribing schemes.
The questions centre upon two points:
1.When the Stafford Group reported to the PHMEG [2] it was at a time
when scientific interest in head lice was still in the doldrums and many
of the guidance points included were based on experience, common sense,
and the best of the older literature.
There was little direct guidance on treatment, other than that what
evidence was available indicated that insecticides had a higher level of
evidence in their favour than otherwise and there were no or fewer
alternative options.
It was also advised, for example, that treatments should not be
applied further down long hair than the positioning of a ponytail band
simply because the authors agreed that a single 50mL bottle should be
spread no further and that under normal circumstances lice would not be
found far away from the scalp.
However, when we used 4% dimeticone we found that the highly mobile
fluid spread along hair shafts and lice “fled” from it, moving away from
the scalp necessitating application of the product to the tips of the
hairs. We found a similar effect, but to a lesser degree, with the
aqueous phenothrin comparator meaning that the guidance requires some
updating at least in that respect.
We also found that some guidance on quantities of product used are
required as the doses we had used to obtain an adequate coverage and a
good therapeutic effect were greater than any previous investigators had
indicated.[1]
2.When several of the Minor Ailment Pharmacy prescribing schemes were
set up, I was asked to provide introductory guidance for staff involved,
including sessions on louse biology and treatment. At the time the best
guidance I was able to offer on insecticide treatment was based on what we
could determine from in vitro studies, determination of resistance
distribution patterns, and latterly from the one clinical study of the
time comparing malathion with wet combing.[3]
That evidence suggested the treatment most likely to be successful in
dealing with most head louse infestations was alcoholic malathion lotion.
As a result, several of the schemes adopted this formulation as their
first line treatment option. Where alcoholic malathion failed, or where
it was unsuitable for a patient, different options were adopted by
different groups, none of which offered a clear solution to the problem.
How does 4% dimeticone fit into the current prescribing schemes? The
answer is that it offers an alternative option for treatment.
Where that option is placed is a matter for local policy makers.
However, as we stated in our report, the product is odourless and non
irritant and will not be affected by resistance to conventional
insecticides.[1]
Since some of the products most favoured by prescribers for those
with sensitive skin and asthma appear to be those most likely to fail due
to insecticide resistance [4] it would seem reasonable that this factor
should be a starting point for those deciding policies related to head
louse treatment, and they should also consider it as an alternative that
may help reduce the overall prevalence of lice by reducing some of the
risks of treatment failure for those families with longer term
infestations.
Irrespective of policy, it will be the public who will ultimately
guide the decision making process by buying treatment over the counter.
Most are prepared to try something new, especially if they have already
experienced large-scale treatment failure with other medications.
Ian F Burgess
References
1.Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation
with 4% dimeticone lotion: randomised controlled equivalence trial BMJ.
2005; 330 (7505): 1423-5
2.Stafford Group. Head lice: evidence-based guidelines based on the
Stafford Report. J Fam Health Care. 2002; 12 (Suppl): 1-21.
3.Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet
combing with malathion for treatment of head lice in the UK: a pragmatic
randomized controlled trial. Lancet. 2000; 356:540-44.
4.Hill N, Moor G, Cameron MM, Butlin A, Preston S, Williamson MS,
Bass C. Single blind, randomised, comparative study of the Bug Buster kit
and over the counter pediculicide treatments against head lice in the
United Kingdom. BMJ. 2005; 331: 384-7.
Competing interests:
IB is a consultant to various companies making pediculicides and combs
Competing interests: No competing interests
In their review entitled ‘More common skin infections in children'
Sladden and Johnston1 suggest that head lice control can be achieved with
a 12 hour application of either 5% permethrin as a dermal cream (off
licence) or 0.5% malathion and that there is good evidence that both
treatments are effective. However, evidence for resistance to both
products has been well documented2. A recently published article
evaluating the efficacy and safety of a 4% dimeticone lotion recorded a
70% cure rate with 16 of the 127 participants reporting side effects3. It
is neither necessary to use neurotoxic chemicals, nor silicone based
products which also require washing off, or to go as far as shaving off
hair4 to control head lice.
A coconut derived emulsion shampoo (CDE) (Lice Attack®) applied by
parents three times in two weeks to dry hair and washed off after 20
minutes produced a 96% efficacy and, when then used twice weekly as a
shampoo, controlled newly acquired infestations5. Hundreds of thousands of
bottles have been sold in Europe and we are not aware of any side effects
other than stinging of eyes, which is well known with many shampoos. In
the USA, where the product is sold over the web with a money back
guarantee for customers not completely satisfied, no one has ever asked
for their money back. The product has no added insecticides and has been
very well received by the participants in our trials. It is perhaps
unfortunate that the BMJ turned down our manuscript describing the results
with CDE and chose to publish on a less effective silicone-based treatment
with recorded side effects. This decision has delayed making both doctors
and parents aware of this excellent novel method of head lice control
using CDE.
Anthony M.R. Downs, Department of Dermatology, Royal Devon Hospital,
Exeter, Devon,
Gerald C.Coles, Kathryn A. Stafford, Department of Clinical Veterinary
Science, University of Bristol, Langford House, Bristol BS40 5DU.
Gerald.c.coles@bristol.ac.uk
Competing interests: none declared
1 Sladden MJ, Johnston GA. More common skin infections in children.
BMJ 2005;330:1194-89 (21 May)
2 Downs, AMR, Stafford, KA, Hunt, LP, Ravenscroft, JC, Coles, GC
Widespread insecticide resistance in head lice to the over-the-counter
pediculocides in England, and the emergence of carbaryl resistance. Br J
Dermatol. 2002; 146: 88-93
3 Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with
4% dimetic0ne lotion: randomised control equivalence trial. BMJ
2005;330:1423-1427 (18 June)
4 Lwegaba A. Shaving can be safer head lice treatment than insecticides.
BMJ 2005; 330: 1510 (June 25)
5 Downs AMR, Connolly M, Stafford KA, Kennedy CTC, Coles GC. A family
based trial of a coconut derived emulsion (CDE) shampoo for head lice
control Br J Dermatol (abstract) 2005 (in press)
Competing interests:
None declared
Competing interests: No competing interests
There are many combing methods in current use for the detection and
treatment of head lice. In comparisons of their effectiveness it is
necessary to be precise. Burgess, Brown and Lee do not state how many
of their trial participants had been provided with a genuine Bug Buster
Kit (www.chc.org) with which to undertake wet combing.(1) A Bug Buster Kit
contains all the appropriate combs and step by step illustrated
instructions for their use plus essential information on breaking the
life-cycle by methodical louse removal, e.g. that the incubation period of
the egg can last 10 days. It cannot be supposed that parents told to use
a ‘nit comb’ with conditioner are testing bug busting wet combing. Also,
Burgess, Brown and Lee are mistaken in thinking that the Kit was submitted
to trial by De Maeseneer and colleagues.(2) The Belgian observational
study used a derivative of the bug busting wet combing protocol, adapted
for mass screening in school, where hair wetting was substituted for hair
washing.(3)
For measuring the outcome of treatment the most sensitive method
should
be used. It remains to be proved in a scientifically designed trial
that combing dry hair with a fine-tooth comb is superior to using a Bug
Buster comb according to the manufacturer’s instructions.
Moreover, without a co-ordinated programme to detect asymptomatic
cases
and treat them at the same time as obvious cases, the recommended
‘whole school approach’, described in the Department of Health leaflet
‘The Prevention and Treatment of Head Lice’(4), much expenditure of
professional and parental time and on products, is wasted.
Community Hygiene Concern, Reg Charity No: 801371
www.chc.org
bugbusters2k@yahoo.co.uk
References
1 Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation
with 4% dimeticone lotion: randomised controlled equivalence trial.
BMJ, doi:10.1136/bmj.38497.506481.8F(10 June 2005).
2 De Maeseneer J, Blokland I, Willems S, Vander Stichele R,
Meersschaut F. Wet combing versus traditional scalp inspection to detect
head lice in schoolchildren: observational study. BMJ 2000;321:1187-1188.
3 Fry F, Ibarra J, Smith J, Wickenden C. Wet combing to eradicate
head lice. J R Soc Med. 2002;95:630-1.
4 www.dh.gov.uk/assetRoot/04/07/59/63/04075963.pdf; available free to
schools from: Department of Health, PO Box 777, London SE1 6XH
(Email:doh@prolog.uk.com)
Competing interests: Community Hygiene Concern is a charity, part-
funded by sales of the Bug Buster Kit on a non-profit making basis.
Competing interests:
Community Hygiene Concern is a charity, part-funded by sales of the Bug Buster Kit on a non-profit making basis.
Competing interests: No competing interests
Dear Sir,
This is not the first report on non-insectiside treatments. I stopped
using insecticides a year or so a go after reading the article in the
BJGP(1) using Dove hair conditioner for headlice. I cured my daughter
after a 12 month recurrent infestation, and now have treated many patients
succesfully. I have used several conditioners and apply them neat to dry
hair in a quantity of about 100mls. This "goo" is is worked into the scalp
and left for 60 minutes then washed off. The theory is that it suffocates
the blighters by blocking their oxygen pores.
Yours sincerely,
Dr Martin Wilkinson
1. Eames E. Simple and Effective Treatment for Headlice. British
Journal of General Practice. 2004:54;786
Competing interests:
None declared
Competing interests: No competing interests
There is always some uncertainty about the sensitivity of any
methodology used for assessment of head louse infestation. Curiously this
infestation is one of the few infectious conditions in which absolute cure
could possibly be determined. However, purity of results must be
subservient to ethical considerations, especially in paediatric studies.
We cannot imagine any ethics committee granting authorisation for a
study in which every participant is effectively cured prior to admission,
and then being reinfected, just so investigators could demonstrate exactly
how many insects were killed by yet another intervention. Also we can
just envisage the look on the faces of some of the parents of our
participants had we proposed to reapply the several hundred, or sometimes
thousands, of lice that would have been removed from their children had we
gone down this path. In a few cases it would have taken all day just to
count the lice from children who were reportedly regularly treated using
the bug busting wet combing method of treatment prior to enrolment in the
study.
If the Lice Snatcher is only as effective as the Bug Buster kit, as
reported by Ms Olsen, it would not have improved the sensitivity of our
detection method as the one trial of Bug busting as a detection method (1)
showed poor sensitivity compared with scalp inspection (2), which in turn
has been shown to be less sensitive than dry combing (3).
Ian F Burgess, Christine M Brown, Peter N Lee.
References:
1. De Maeseneer J, Blokland I, Willems S, Vander Stichele R,
Meersschaut F. Wet combing versus traditional scalp inspection to detect
head lice in schoolchildren: observational study. BMJ 2000; 321: 1187-8.
2. Berger MY, Bueving HJ, Konig S, Schouten BWV. Wet combing no
better than classical scalp inspection to detect head lice. BMJ
http://bmj.bmjjournals.com/cgi/eletters/321/7270/1187#11085 (1 December
2000)
3. Mumcuoglu KY, Friger M, Ioffe-Uspensky I, Ben-Ishai F, Miller J.
Louse comb versus direct visual examination for the diagnosis of head
louse infestations. Pediatr Dermatol 2001; 18: 9-12.
Competing interests:
IFB has been a consultant to various makers of pharmaceutical products, alternative therapies, and combs for treating louse infestations. PNL has analysed similar studies for other pharmaceutical companies.
Competing interests: No competing interests
22 June 2005 Response to Burgess,
Brown & Lee
Head Lice: standards in clinical trial design
Head lice infest children all over the world nowadays, a troublesome and
time-consuming problem, so any serious attempts to find non-toxic
products/methods to get rid of them are to be appreciated. However, I
have a general reservation about the evaluation of cure rates by loosely
comparing pre- and post- treatment louse counts, as Burgess and colleagues
(1) have done. In the trial they describe, accurate data on which to base
the comparison have not been collected.
In Denmark a device has been developed, called Lice Snatcher (2).
Attached to a household vacuum cleaner, it removes hatched lice from dry
hair. It filters them into a detachable box; the lice can then be counted
and classified into developmental stages. They remain live and healthy
and can be returned unharmed to the head afterwards. Treatment with
medication can then proceed with an accurate knowledge of the degree of
infestation on the head. If the pre-treatment infestation consists
entirely of full-grown adults, it is recent, as mature lice migrate from
head to head and smaller lice usually remain on the head where they hatch.
If all three nymphal stages and full-grown lice are present, the
infestation has been active for some time. A post-treatment test should
be made when the medication has been washed off and the hair dried to
establish its capacity to kill lice, and again on days 4, 8 and 12 to test
its capacity to kill eggs. Head louse eggs hatch during a period of 10
days post-oviposition. Therefore if the tests on days 4, 8 and 12 reveal
any 1st and 2nd stage nymphs, the treatment is not ovicidal.
Head lice are ectoparasites and must be looked upon as such; the cure
is not necessarily medication, which can have dubious side-effects. My
trials using the Bug Buster Kit (3) to check the accuracy of the Lice
Snatcher showed that it was just as efficient as bug busting wet combing
at removing lice from the head (unpublished findings). Both these
physical methods can break the life-cycle on the basis of systematically
removing lice from the head.
To compare the effort required to use these ‘slow’ physical methods
with medication, data are required on whether the formula stains clothing
and bedding and how easily it can be washed from the head after
application (especially if multiple applications are involved). No
information on this or other points in relation to the consumer
acceptability of 4% dimeticone lotion is given by Burgess and colleagues
(1).
In my opinion the issues I raise above must be resolved to set
uniform standards for clinical trials of treatments for head lice.
443 words
Alice Olsen, M.sc. biology
Project Leader Idéværkstedet De Frie Fugle www.friefugle.dk
www.hovedlus.dk
Måløvhøjvej 24, DK2750 Ballerup Denmark alice@hovedlus.dk
References
1 Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation
with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ,
doi:10.1136/bmj.38497.506481.8F(10 June 2005).
3 Ibarra J, Fry F, Wickenden C, Smith JL. Head lice: Accurate
knowledge of the life-cycle is essential to achieve control. bmj.com Rapid
Responses for Sladden and Johnston, 330 (7501) 1194-1198.
Competing interests: None – I have not and have never had any
commercial interests in ‘louse products’. I was formerly an employee of
the Danish Pest Control Laboratory 1980-97. Sponsored by the Danish
Ministry of Environment, in 1999 I evaluated the Bug Buster Kit and found
bug busting wet combing is a consumer friendly and efficient method for
the detection and control of head lice.
Competing interests:
None declared
Competing interests: No competing interests
It was helpful to find considerable detail in the electronic BMJ
Online First report by Burgess and colleagues of a randomised controlled
equivalence trial of 4% dimeticone lotion for the treatment of head
infestation (1). The trial is welcome as in depth studies of alternatives
to conventional insecticides are very necessary. However, we have
reservations on some methodological points.
We agree that fine-tooth combing dry hair is valid to confirm active
infestation in trial entrants. However, the sensitivity of the detection
method used to assess the outcome of treatment will affect the result,
less reliable methods producing over-optimistic results. The authors have
not justified the choice of combing dry hair at this stage, in preference
to the bug busting wet combing (BBWC) method previously recommended (2).
This is odd because lice are described moving swiftly away from
disturbance during the application of lotion to dry hair. This same
reaction to combing in dry hair can allow some lice to escape detection.
Thoroughly wet lice remain motionless facilitating their removal with a
fine-tooth comb. BBWC makes doubly sure that lice are not missed: firstly
shampooed hair prepared with ample conditioner is combed and then the
combing is repeated in the rinsed hair (3). We suggest that the 69% cure
rate with dimeticone reported in this study should be verified using BBWC.
The fact that some louse eggs hatch at least 10 days post laying is
not addressed in this study. On the evidence available, two applications,,
made a week apart, of any formula that does not kill the egg stage with
certainty, may not finally eradicate infestation. In practice, we
consider it is wise to follow the Department of Health advice to make a
thorough check for lice 5 days and 12 days after the initiation of
treatment to assess progress (4).
Joanna Ibarra, Programme Co-ordinator,
Frances Fry, Development Worker,
Clarice Wickenden, Project Co-ordinator,
Jane Leseley Smith, Project Worker
Community Hygiene Concern, Reg Charity No: 801371
www.chc.org,
bugbusters2k@yahoo.co.uk
References
1 Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation
with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ,
doi:10.1136/bmj.38497.506481.8F(10 June 2005).
2 Bingham P, Kirk S, Hill N, Figueroa J. The methodology and
operation of a pilot randomized control trial of the effectiveness of the
Bug Busting method against a single application insecticide product for
head louse treatment. Public Health 2000; 114:265-268.
3 Ibarra J. Pediculosis. In: Figueroa J, Hall S, Ibarra J, eds.
Primary Health Care Guide to Common UK Parasitic Diseases. Community
Hygiene Concern, London, 1998: 1-24
4 Department of Health. The Prevention and Treatment of Head Lice.
DOH, London, 2000
Competing interests:
Community Hygiene Concern is a charity, part-funded by sales of the Bug Buster Kit on a non-profit making basis.
Competing interests: No competing interests
Raising the standard of the labelling and instruction leaflets of treatments for head lice
The National Health Service (NHS) seeks to promote self-care for
minor ailments such as head lice, with health professionals in a
supporting role. Burgess, Brown and Lee suggest the problem of under-
dosing in the community with formulated products could be improved with
“better instructions for use and improved information at the primary care
level” (1). We agree and furthermore we consider that inadequate
labelling and product instructions, running in tandem with guidelines for
health professionals (2, 3) which give conflicting advice, are a major
obstacle to successful eradication. This rebounds on health professionals
at a huge cost to the NHS (4).
Failure to base treatment recommendations on an accurate knowledge of
the life-cycle of the head louse (5) compounds the confusion. It must be
acknowledged that there is no formulated product available which kills
eggs with certainty, and some perform so poorly against hatched lice that
“they potentially expose users to repeat applications without any
important reduction in infestations” (6). The situation is illustrated by
a report to the Welsh Assembly in 2003 of an 8.3% prevalence rate of head
lice in primary school children, double that reported in 2000 (7). Across
the UK distress and anger prevail among parents whose expectations of a
solution are raised by promises on product labelling e.g. “a single
application ... will kill head lice and their eggs”, “for
the fast effective treatment of head lice and their eggs” and then dashed.
In the interest of the public health and fairness to product users,
evidence should be produced by clinical evaluation in the UK community
where parents follow the manufacturers’ instructions. Information on the
quantity to use, the time to leave it on the head, and the number of
applications is required. The practicality of the application and removal
methods should be assessed. Realistic statements such as “Enough for one
application to shoulder length hair”, “X minutes/hours application time”
and “X number of applications required to complete treatment” should
appear on a product label. For products containing insecticides to which
lice become resistant, the date of the last clinical evaluation should be
displayed with the percentage success rate. An accurate statement on the
incubation period of head louse eggs, the consequent need to make a
thorough check for lice 5 and 12 days after treatment applications, and
the appropriate practical tips about product use should always be included
in the instructions.
We call for an open debate of these issues which places the
regulatory framework in the public domain.
Joanna Ibarra, Programme Co-ordinator,
Frances Fry, Development Worker,
Clarice Wickenden, Health Education Adviser,
Jane Lesely Smith, Assistant Development Worker
Community Hygiene Concern, Reg Charity No: 801371, Manor Gardens
Centre, 6-9 Manor Gardens, London N7 6LA
www.chc.org
bugbusters2k@yahoo.co.uk
References
(1) Burgess IF, Brown CM, Lee PN. (2005)Treatment of head louse
infestation with 4% dimeticone lotion: randomised controlled equivalence
trial. BMJ 330: 1423-5 (Full text Online first, BMJ,
doi:10.1136/bmj.38497.506481.8F(10 June 2005)
(2) Joint Formulary Committee. British National Formulary, entry
13.10.4, Parasiticidal preparations. London: British Medical Association
and Royal Pharmaceutical Society of Great Britain, 1981- (updated March
and September each year)
(3) Aston R, Duggal H, Simpson J, advised by Burgess I, Medical
Entomology Centre, Cambridge. Head lice. Report for Consultants in
Communicable Disease Control (CCDCs) 1998 (www.fam-
english.demon.co.uk/phmeghl.htm)
(4) Board NJ. Professional carer experience.
http://bmj.bmjjournals.com/cgi/eletters/331/7513/384 (20 November 2005)
(5) Buxton P A. The Louse. An account of the lice which infest man,
their medical importance and control. London: Edward Arnold & Co,
1947
(6) Hill N, Moor G, Cameron MM, Butlin A, Preston S, Williamson MS,
Bass C. Single blind, randomised, comparative study of the Bug Buster kit
and over the counter pediculicide treatments against head lice in the
United Kingdom. BMJ 2005; 311: 384-6 (Full text Online first, BMJ,
doi:10.1136/bmj.38537.468623.EO (5 August 2005)
(7) Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet
combing with malathion for treatment of head lice in the UK: a pragmatic
randomised controlled trial. Lancet 2000;356: 540-4
Competing interests:
Community Hygiene Concern is a charity, part-funded by sales of the Bug Buster Kit on a non-profit making basis.
Competing interests: No competing interests